Vivo Capital, LLC Oric Pharmaceuticals, Inc. Transaction History
Vivo Capital, LLC
- $472 Million
- Q2 2025
A detailed history of Vivo Capital, LLC transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Vivo Capital, LLC holds 3,126,604 shares of ORIC stock, worth $29.8 Million. This represents 6.72% of its overall portfolio holdings.
Number of Shares
3,126,604
Previous 2,080,450
50.28%
Holding current value
$29.8 Million
Previous $11.6 Million
173.39%
% of portfolio
6.72%
Previous 3.15%
Shares
6 transactions
Others Institutions Holding ORIC
# of Institutions
146Shares Held
91.8MCall Options Held
1.03MPut Options Held
10.1K-
Nextech Invest, Ltd. Zurich, V87.16MShares$68.2 Million13.76% of portfolio
-
Vr Adviser, LLC New York, NY6.6MShares$62.8 Million13.26% of portfolio
-
Viking Global Investors LP6.57MShares$62.6 Million0.21% of portfolio
-
Nextech Invest Ag5.29MShares$50.3 Million7.95% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$46 Million0.0% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $377M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...